• 2 months 3 weeks ago Help us improve our website: http://t.co/vY9vRzmYRH! Please take our visitor survey: http://t.co/8gY0wRZtGx. Thank you...
  • 2 months 3 weeks ago 1st European Research Forum on Healthy Ageing: 03 Sept in Bxl. Policy makers, scientists, industrials: save the date! http://t.co/6TXrBI5rdt
  • 3 months 4 days ago Gender inequalities in health: a matter of policies according to @sophieproject http://t.co/TzwZzXko3g
  • 4 months 1 day ago 1/3 of cancer patients killed by 'fat-burning' process termed cachexia, @CNIO_Cancer researchers say http://t.co/GjfipsdG2R
  • 4 months 4 weeks ago New EU research project @pneumonp aims to tackle antibiotic resistance via inhalable nano therapeutics #nanomedicine http://t.co/VQN9WHojG2
  • 5 months 2 weeks ago Urban renewal improves the health of neighbours in Barcelona according to EU-funded project @sophieproject http://t.co/F0mKCdPBZ5
  • 5 months 2 weeks ago Check this article on #CommHERE: how to spread the word about research and reach out beyond the scientific community http://t.co/VDcKVDEfcc
  • 6 months 2 weeks ago Scientists @CNIO_Cancer among the 40 most important global researchers http://t.co/Rc0hIsq6dN
  • 6 months 3 weeks ago 2nd workshop @CIBER_ISCIII to strengthen the EU‐LAC Health Research Cooperation http://t.co/93qLQObcQj
  • 8 months 2 weeks ago The European Symposium in Drug Synthesis @unisiena will take place on May 18-23. You can register until April 15!! http://t.co/V8kxQIev9S

DEEP

Prof. Adriana Ceci

Scientific Coordinator of DEEP, based at the University Aldo Moro, Bari, Italy

Research field

Medicines for Children

If you like this
If you want to know more
Research Profile

Who?

Adriana Ceci is an Associate Professor of Paediatrics and a member of the Paediatric Committee of the European Medicines Agency. She is enthusiastic when she talks about the DEEP project: “I’m very satisfied that the development of medicines for children is finally recognised as a fundamental issue at the European level.”

Why?

Worldwide, about 60,000 children are born with thalassemia every year. Frequent blood transfusions can ensure adequate oxygen carrying capacity in patients. However, the transfusions result in an accumulation of iron in the body. Deferiprone can remove the excess iron, but the correct dosage for children is uncertain.

What?

DEEP aims to determine the correct doses of deferiprone in children of different ages. Deferiprone is prescribed to patients with thalassemia, a severe inherited form of anaemia. The proper use of deferiprone in children is a challenge because, like most drugs, it has only been tested on adults in clinical trials.

How?

DEEP is a multi-national network of researchers that face the complex task of conducting clinical trials in children. The European collaboration allows us to share our expertise. Our major challenge is the development of protocols in accordance with ethical and methodological standards and international recommendations.

Developing drugs for children: children are not small adults

In the Picture
In the Picture
Image credits

Background image: DEEP

Portrait of the project coordinator: DEEP

Timeline (in chronological order): DEEP